Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased thromboxane biosynthesis in essential thrombocythemia

B Rocca1, G Ciabattoni, R Tartaglione

  • 1Department of Medicine, Catholic University School of Medicine, Rome, Italy.

Thrombosis and Haemostasis
|November 1, 1995
PubMed
Summary

Essential thrombocythemia (ET) patients show higher thromboxane (TX) biosynthesis, indicated by elevated urinary 11-dehydro-TXB2 levels. Age and platelet count influence this activation, aiding risk assessment and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is the role of physical exercise after surgery for gastric cancer? A scoping review.

ESMO gastrointestinal oncology·2026
Same author

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

Radiation research·2023
Same author

RENEB Inter-Laboratory Comparison 2021: The Cytokinesis-Block Micronucleus Assay.

Radiation research·2023
Same author

RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

Radiation research·2023
Same author

A NOVEL BIOLOGICAL DOSIMETRY ASSAY AS A POTENTIAL TOOL FOR TRIAGE DOSE ASSESSMENT IN CASE OF LARGE-SCALE RADIOLOGICAL EMERGENCY.

Radiation protection dosimetry·2019
Same author

Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2017

Area of Science:

  • Hematology
  • Cardiovascular Research
  • Biochemistry

Background:

  • Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • Thromboxane A2 (TXA2) plays a role in platelet activation and thrombosis.
  • Understanding in vivo TX biosynthesis in ET is crucial for risk stratification.

Purpose of the Study:

  • To investigate in vivo thromboxane (TX) biosynthesis in essential thrombocythemia (ET).
  • To assess the relationship between TX metabolite excretion and clinical factors like age and platelet count in ET patients.
  • To evaluate the effect of low-dose aspirin on TX biosynthesis in ET.

Main Methods:

  • Measurement of urinary 11-dehydro-TXB2 and 2,3-dinor-TXB2 in 40 ET patients and 26 controls.

Related Experiment Videos

  • Analysis of urinary metabolite excretion in relation to platelet count and age.
  • Assessment of aspirin's effect on 11-dehydro-TXB2 levels in a subset of patients.

    • Main Results:

    • Urinary 11-dehydro-TXB2 was significantly higher in ET patients compared to controls (p < 0.001).
    • Elevated levels were observed in patients with lower platelet counts (< 1,000 x 10(9)/L) and those older than 55.
    • Low-dose aspirin significantly suppressed 11-dehydro-TXB2 excretion, suggesting platelet origin.

    Conclusions:

    • Enhanced urinary 11-dehydro-TXB2 excretion in ET reflects in vivo platelet activation.
    • Age and platelet count are significant factors influencing platelet activation in ET.
    • These findings can aid in assessing thrombotic risk and guiding therapeutic strategies in ET patients.